# Discriminator report

## Scenario echo
The scenario is human pancreas with no cell type restriction, unspecified age and sex, and baseline/healthy condition; notes are null, so the embedding should cover the normal human pancreas cell-type and resident-state landscape without a special structural emphasis.

## Rating: minor
The blueprint is broadly plausible and covers the major exocrine, endocrine, vascular, stromal, and immune compartments with reasonable markers and a sensible gated endocrine subtype design. It still misses a small number of expected whole-pancreas resident populations, so it is not quite complete enough to defend unchanged.

## Findings

### Minor issues
- **General coverage / axes** — There is no axis for pancreatic neural/glial cells, especially Schwann/peripheral glial cells that appear as resident or peri-islet/perivascular support populations in whole-pancreas atlases. The current stromal and pericyte axes will not capture a S100B/SOX10/PLP1/MPZ-type glial program.
  *Fix:* Add a neural/glial or Schwann-cell module and plain axis using canonical peripheral glial markers such as `SOX10`, `S100B`, `PLP1`, `MPZ`, `GFRA3`, `NGFR`, and/or `GAP43`, supported by a pancreas atlas or appropriate high-impact peripheral glia reference.
- **General coverage / axes** — Mesothelial/capsular serosal cells are not represented. For a celltype-null pancreas scenario, a small but distinct mesothelial population is plausible in whole-tissue/capsule-inclusive data and is not well handled by the generic ductal or fibroblast modules.
  *Fix:* Add a mesothelial/capsular epithelial module and plain axis if supported by the selected human pancreas atlas evidence, with markers such as `MSLN`, `WT1`, `UPK3B`, `KRT19`, `KRT8`, `KRT18`, and `CALB2`. If the Generator cannot ground this in qualifying literature, omit it rather than inventing it.
- **ductal_epithelial / axis granularity** — The ductal module is a single broad ductal axis. This is acceptable for coarse coverage, but it may blur canonical ductal/centroacinar bicarbonate-transport programs and mucinous/large-duct programs if the expected input is whole pancreas rather than islet-enriched data.
  *Fix:* Consider either enriching the existing ductal module with more duct/centroacinar functional markers (`KRT19`, `SOX9`, `CFTR`, `SLC4A4`, `SLC26A6`, `ANXA4`, `TFF1`/`MUC1` where supported) or adding a separate centroacinar/ductal-refinement axis only if literature support is strong.
- **epsilon_cell** — The epsilon-cell axis is biologically plausible but the module is very small and partly generic endocrine (`ISL1`, `CHGA`, `PCSK1`), so it may mostly recapitulate endocrine-core signal plus `GHRL` rather than cleanly resolving rare epsilon/ghrelin cells.
  *Fix:* Strengthen the epsilon module with additional supported ghrelin/epsilon markers if available, or leave the axis but reduce reliance on generic endocrine genes in favor of more specific markers. Do not delete the axis solely because the population is rare, since age is unspecified.

## Out of scope (FYI, not actionable for the Generator)
- Citation and DOI verification were not reassessed here; the judgment is limited to biological coverage, axis design, marker plausibility, and structural conformance.

## Summary for the next round
Keep the current major-compartment structure and endocrine gating. The next Generator should focus on adding grounded axes for Schwann/peripheral glial and, if supportable, mesothelial/capsular cells, then lightly improve ductal and epsilon marker specificity without deleting the existing core pancreas axes.
